FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 278

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CABR Nasdaq Caring Brands, Inc. 2830
CAMP Nasdaq Camp4 Therapeutics Corporation 2830
CANF NYSE American Can-Fite BioPharma Ltd. 2830
CASI Nasdaq CASI Pharmaceuticals, Inc. 2830
CATX NYSE American Perspective Therapeutics, Inc. 2830
CBIO Nasdaq Crescent Biopharma, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq CDT Equity Inc. 2830
CELZ Nasdaq Creative Medical Technology Holdings, In 2830
CGC Nasdaq Canopy Growth Corporation 2830
CGEN Nasdaq Compugen Ltd. 2830
CHRS Nasdaq Coherus Oncology, Inc. 2830
CING Nasdaq Cingulate Inc. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLLS Nasdaq Cellectis S.A. 2830
CLSD Nasdaq Clearside Biomedical, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
CNTA Nasdaq Centessa Pharmaceuticals plc 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPRX Nasdaq Catalyst Pharmaceuticals, Inc. 2830
CRBP Nasdaq Corbus Pharmaceuticals Holdings, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CUPR Nasdaq Cuprina Holdings (Cayman) Limited 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
DTIL Nasdaq Precision BioSciences, Inc. 2830
DWTX Nasdaq Dogwood Therapeutics, Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2830
ELVN Nasdaq Enliven Therapeutics, Inc. 2830
ENGN Nasdaq enGene Holdings Inc. 2830
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
EVGN Nasdaq Evogene Ltd. 2830
EVO Nasdaq Evotec SE 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
FGEN Nasdaq FibroGen, Inc. 2830
FHTX Nasdaq Foghorn Therapeutics Inc. 2830
GALT Nasdaq Galectin Therapeutics Inc. 2830
GILD Nasdaq Gilead Sciences, Inc. 2830
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2830
Results 50 through 100 of 278